October 15, 2025 · Giorgio Ricciardiello
Electronic Health Record (EHR) integration is frequently cited as both the most desired and most dreaded technology initiative in sleep medicine practices. The promise — seamless data flow between scheduling, testing, scoring, and clinical documentation — is compelling. The reality often involves fragmented vendor ecosystems, inconsistent data standards, and implementation timelines that stretch far beyond initial estimates.
This article addresses the practical considerations that sleep clinic owners and IT decision-makers should evaluate before embarking on an EHR integration project.
Sleep labs typically operate with a technology stack that spans multiple vendors: a scheduling/practice management system, a PSG acquisition and scoring platform, an EHR for clinical documentation, and potentially separate systems for durable medical equipment (DME) tracking and patient communication.
The fundamental challenge is that these systems were not designed to communicate with each other.
Before evaluating integration options, clinics must map their actual data flows:
Option A: Point-to-Point API Integration
Option B: Integration Engine (Middleware)
Option C: Unified Platform
Poorly implemented EHR integration creates more problems than it solves. Clinics should expect a 2–4 week validation period after go-live, during which parallel workflows (manual + automated) should run simultaneously to verify data integrity.
EHR integration is not a technology problem — it is a workflow design problem that requires technology solutions. Start with a complete data flow map, evaluate integration architecture against your clinic's scale and complexity, and budget for validation and iteration. The cost of doing it right is always less than the cost of fixing a rushed implementation.
A practical roadmap for sleep clinic owners looking to reduce administrative burden through intelligent automation — from scheduling to reporting.
Exploring how wrist-worn accelerometer data from consumer wearables can identify early markers of neurodegenerative disease.